Financial Architects, Inc Biogen Inc. Transaction History

Financial Architects, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $312,354 - $500,140	-1,206 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $292,997 - $343,263	1,206 New	1,206 $337,000
Q3 2020 Nov 09, 2020	SELL	$264.77 - $305.71 $13,503 - $15,591	-51 Closed	0 $0
Q3 2019 Nov 06, 2019	SELL	$217.44 - $243.88 $6,523 - $7,316	-30 Reduced 37.04%	51 $12,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $18,420 - $20,304	-84 Reduced 50.91%	81 $19,000
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $35,757 - $55,928	165 New	165 $39,000
Q1 2019 May 03, 2019	SELL	$216.71 - $338.96 $23,404 - $36,607	-108 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$278.5 - $352.75 $6,962 - $8,818	-25 Reduced 18.8%	108 $32,000
Q2 2018 Aug 03, 2018	SELL	$257.52 - $306.91 $4,377 - $5,217	-17 Reduced 11.33%	133 $39,000
Q4 2017 Feb 12, 2018	SELL	$307.64 - $344.58 $246,112 - $275,664	-800 Reduced 84.21%	150 $48,000
Q3 2017 Nov 01, 2017	BUY	$281.15 - $329.69 $259,501 - $304,303	923 Added 3418.52%	950 $298,000
Q3 2017 Oct 23, 2017	BUY	$281.15 - $329.69 $7,591 - $8,901	27	27 $8,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.